TOP
お知らせ
プレスリリース
企業案内
製品
導入事例
COVID-19 Archive
マンガシリーズ
研究開発
イベント情報
採用情報
お問い合わせ
English
COVID-19 Archive
COVID-19 Archive|2021
絞り込み
期間:
すべての期間
2021
2020
キーワード:
#すべて
#ウイルス学・疫学
#リスク因子・重症化リスク因子
#ワクチン
#基礎研究
#小児・妊婦
#感染伝播・予防策
#検査・診断
#治療薬・治療法
#病態
#臨床症状
#臨床研究
2021.03.15
Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study (BMJ 2021.3.10)
2021.03.11
Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study (Epub 2020.10.29)
2021.03.07
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial (JAMA 2021.3.4)
2021.03.05
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 (JAMA 2021.3.3)
2021.03.03
ROGUE ANTIBODIES COULD BE DRIVING SEVERE COVID-19 (Nature 2021.1.19)
2021.03.02
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting (NEJM 2021.2.24)
2021.03.02
The Johnson & Johnson Vaccine for COVID-19 (JAMA 2021.3.1)
2021.03.02
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19 (NEJM 2021.2.25)
2021.03.01
Autoantibodies against type I IFNs in patients with life-threatening COVID-19 (Science 2020.10.23)
2021.02.25
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial (Lancet 2020.11.12)
2021.02.24
How soon will COVID-19 vaccines return life to normal? (Science 2021.2.16)
2021.02.15
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US--December 14, 2020-January 18, 2021(JAMA 2021.2.12)
2021.02.08
Monoclonal Antibodies for COVID-19 (JAMA 2021.2.5)
2021.02.05
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine (N Eng J Med 2021.2.4)
2021.01.07
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers (The New England Journal of Medicine 2020.12.23)
1
2